MISSION Therapeutics is a biotechnology company that specializes in developing drugs targeting deubiquitylating enzymes (DUBs) for the treatment of various diseases, including Parkinson's. They have a rich pipeline of first-in-class therapeutics that selectively target specific disease-associated DUBs, such as USP30. With a collaborative and science-driven culture, they have strong links to key ac...